1. Home
  2. NMTC vs SACH Comparison

NMTC vs SACH Comparison

Compare NMTC & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.71

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.22

Market Cap

46.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
SACH
Founded
2009
2010
Country
United States
United States
Employees
N/A
27
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
46.9M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
NMTC
SACH
Price
$3.71
$1.22
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$11.90
$2.00
AVG Volume (30 Days)
31.0K
535.0K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
19.23%
EPS Growth
80.43
N/A
EPS
N/A
N/A
Revenue
$9,097,692.00
N/A
Revenue This Year
N/A
$145.00
Revenue Next Year
$31.90
$6.80
P/E Ratio
N/A
N/A
Revenue Growth
163.47
N/A
52 Week Low
$0.55
$0.90
52 Week High
$5.40
$1.45

Technical Indicators

Market Signals
Indicator
NMTC
SACH
Relative Strength Index (RSI) 46.24 57.54
Support Level $0.69 $0.99
Resistance Level $4.87 N/A
Average True Range (ATR) 0.37 0.10
MACD -0.21 0.02
Stochastic Oscillator 5.66 47.62

Price Performance

Historical Comparison
NMTC
SACH

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.

Share on Social Networks: